Current Pharmaceutical Biotechnology
Title:Editorial (Thematic Issue: Molecular Image-Guided Cancer Treatment: Moving Towards Personalized Medicine-Part II)
Volume: 14 Issue: 8
Author(s): Zhaofei Liu
Affiliation:
Export Options
About this article
Cite this article as:
Liu Zhaofei, Editorial (Thematic Issue: Molecular Image-Guided Cancer Treatment: Moving Towards Personalized Medicine-Part II), Current Pharmaceutical Biotechnology 2013; 14 (8) . https://dx.doi.org/10.2174/138920101408140122151945
DOI https://dx.doi.org/10.2174/138920101408140122151945 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Player on An Old Field; the Keap1/Nrf2 Pathway as a Target for Treatment of Type 2 Diabetes and Metabolic Syndrome
Current Diabetes Reviews p53-Independent Activities of MDM2 and Their Relevance to Cancer Therapy
Current Cancer Drug Targets Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Central Nervous System Agents in Medicinal Chemistry A Comprehensive Review on Oxysterols and Related Diseases
Current Medicinal Chemistry Strategies for Developing Tuberculosis Vaccines: Emerging Approaches
Current Drug Targets From Head to Tail: Microwave-Assisted Synthesis of Para Hydrazine Nicotinamide Phenylalanine8-Oxytocin Derivatives
Letters in Organic Chemistry Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties
Current Medicinal Chemistry How Cancer Cells Resist Chemotherapy: Design and Development of Drugs Targeting Protein-Protein Interactions
Current Topics in Medicinal Chemistry Pre-Clinical Considerations in the Assessment of Immunogenicity for Protein Therapeutics
Current Drug Safety The Ubiquitous Choline Transporter SLC44A1
Central Nervous System Agents in Medicinal Chemistry Molecular Targets and Targeted Therapies for Malignant Mesothelioma
Current Medicinal Chemistry New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook
Current Drug Delivery Biomedical Applications of Gold Nanoparticles
Current Topics in Medicinal Chemistry Nanoparticle Engineering Enhances Anticancer Efficacy of Andrographolide in MCF-7 Cells and Mice Bearing EAC
Current Pharmaceutical Biotechnology Synthesis and Cytotoxic Evaluation of Novel Symmetrical Taspine Derivatives as Anticancer Agents
Medicinal Chemistry Testosterone Deficiency Syndrome: Cellular and Molecular Mechanism of Action
Current Aging Science HSP60 as a Drug Target
Current Pharmaceutical Design Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug
Anti-Cancer Agents in Medicinal Chemistry Virtual Screening of Natural Products to Select Compounds with Potential Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Engineered Nanoparticles in Cancer Therapy
Recent Patents on Drug Delivery & Formulation